Ralimetinib (LY2228820) dimesylate

Ask supplier a question | View on supplier's website

Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.

Supplier	Selleck Chemicals
Product #	S1494
Sku #	S1494-10mM/1mL
Pricing	10mM/1mL, $286.00

Feedback